Published in Pediatr Res on January 01, 1976
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell (2000) 5.23
Fetal growth and perinatal viability in California. Obstet Gynecol (1982) 5.23
Mefloquine (WR 142,490) in the treatment of human malaria. Science (1975) 5.20
The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow. Circ Res (1967) 5.05
Identifying the sources of the recent decline in perinatal mortality rates in California. N Engl J Med (1982) 4.64
Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis (1977) 4.57
The first night effect: an EEG study of sleep. Psychophysiology (1966) 3.86
Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature (1999) 3.81
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell (2000) 3.68
Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med (1976) 3.30
Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol (1972) 3.17
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med (1997) 3.13
Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta. Nature (1996) 3.11
Cesarean section, fetal monitoring, and perinatal mortality in California. Am J Public Health (1979) 3.04
Pregnancy outcomes among Spanish-surname women in California. Am J Public Health (1986) 3.04
Cesarean section in California--1960 through 1975. Am J Obstet Gynecol (1979) 2.81
Reducing black neonatal mortality. Will improvement in birth weight be enough? JAMA (1985) 2.56
Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell (1993) 2.52
Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52
The crystal structure of the PX domain from p40(phox) bound to phosphatidylinositol 3-phosphate. Mol Cell (2001) 2.47
Computer analysis of Staphylococcus aureus phage typing data from 1957 to 1975, citing epidemiological trends and natural evolution within the phage typing system. Appl Environ Microbiol (1980) 2.40
Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest (1966) 2.38
The natural history of ventricular septal defects in infancy. Am J Cardiol (1965) 2.18
Cardiovascular responses to hypoxemia and acidemia in fetal lambs. Am J Obstet Gynecol (1974) 2.18
The changes in the circulation after birth. Their importance in congenital heart disease. Circulation (1970) 2.18
Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther (1976) 2.04
Bias and 'overcall' in interpreting chest radiographs in young febrile children. Pediatrics (1992) 1.97
Use of radioactive microspheres to assess distribution of cardiac output in rabbits. Am J Physiol (1968) 1.94
Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med (1972) 1.93
Echocardiographic assessment of ductus arteriosus shunt in premature infants. Circulation (1974) 1.90
The fetal circulation and its response to stress. J Dev Physiol (1984) 1.87
Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol (1975) 1.81
Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation (1981) 1.76
Congenital obstructive lesions of the right aortic arch. Ann Thorac Surg (1999) 1.76
Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J Biol Chem (1998) 1.75
Monitoring perinatal mortality rates: California, 1970 to 1976. Am J Obstet Gynecol (1980) 1.70
Femoral nerve block in extracapsular femoral neck fractures. J Bone Joint Surg Br (1995) 1.70
Empirical solvation models can be used to differentiate native from near-native conformations of bovine pancreatic trypsin inhibitor. Proteins (1991) 1.65
Measuring the effectiveness of perinatal medical care. Med Care (1979) 1.63
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63
Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev Biol (1990) 1.61
Intrauterine growth curves: intra- and international comparisons with different ethnic groups in California. Prev Med (1975) 1.61
Circulatory changes during growth in the fetal lamb. Circ Res (1970) 1.56
The value of USP public standards for therapeutic products. Pharm Res (2004) 1.54
Nocturnal erections, differential diagnosis of impotence, and diabetes. Biol Psychiatry (1977) 1.54
Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res (1985) 1.53
Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays (1995) 1.52
Nonlinear theophylline elimination. Clin Pharmacol Ther (1982) 1.51
Cardiac malpositions. An overview based on study of sixty-five necropsy specimens. Circulation (1977) 1.51
Acute spontaneous spinal epidural hematomas. AJNR Am J Neuroradiol (1999) 1.50
Newborn risk factors and costs of neonatal intensive care. Pediatrics (1981) 1.50
Controlling the rise in cesarean section rates by the dissemination of information from vital records. Am J Public Health (1983) 1.49
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol (1983) 1.48
Chronic compartment syndrome, an important cause of work-related upper limb disorder. Rheumatology (Oxford) (2005) 1.48
CT and MR imaging features of pyogenic ventriculitis. AJNR Am J Neuroradiol (2001) 1.48
Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution. Proc Natl Acad Sci U S A (1991) 1.46
Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol (1990) 1.46
Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Bull World Health Organ (1974) 1.45
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS (1990) 1.44
Structural and mechanistic comparison of prokaryotic and eukaryotic phosphoinositide-specific phospholipases C. J Mol Biol (1998) 1.43
Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives. J Clin Pharmacol (2000) 1.43
Hepatic disease and drug pharmacokinetics. Clin Pharmacokinet (1981) 1.42
The comparative effectiveness of group and individually contingent free time with inner-city junior high school students. J Appl Behav Anal (1973) 1.41
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
Fetal and neonatal pulmonary circulation. Annu Rev Physiol (1979) 1.39
Use of assisted reading to improve reading rate, word accuracy, and comprehension with ESL Spanish-speaking students. Percept Mot Skills (1994) 1.38
Persistent pulmonary hypertension of the newborn infant. J Pediatr (1976) 1.37
Mapping the phospholipid-binding surface and translocation determinants of the C2 domain from cytosolic phospholipase A2. J Biol Chem (1999) 1.37
A revised structure for fucoidan may explain some of its biological activities. J Biol Chem (1993) 1.35
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol (1985) 1.35
Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation (1981) 1.34
Changes in the pulmonary circulation during birth-related events. Pediatr Res (1990) 1.32
Crystal structure of a diabody, a bivalent antibody fragment. Structure (1994) 1.32
Catalytic domain of phosphoinositide-specific phospholipase C (PLC). Mutational analysis of residues within the active site and hydrophobic ridge of plcdelta1. J Biol Chem (1998) 1.32
Replacements of single basic amino acids in the pleckstrin homology domain of phospholipase C-delta1 alter the ligand binding, phospholipase activity, and interaction with the plasma membrane. J Biol Chem (1998) 1.32
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Pharm Res (1998) 1.31
Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med (1982) 1.30
Calcium-dependent membrane penetration is a hallmark of the C2 domain of cytosolic phospholipase A2 whereas the C2A domain of synaptotagmin binds membranes electrostatically. J Biol Chem (1998) 1.29
Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther (1983) 1.27
Prevalence of sleep disturbance in a primarily urban Florida County. Soc Sci Med (1976) 1.26
The intrinsic helix-forming tendency of L-alanine. Proc Natl Acad Sci U S A (1992) 1.26
Development of baroreflex activity in unanesthetized fetal and neonatal lambs. Circ Res (1972) 1.25
Phospholipase C delta 1 requires a pleckstrin homology domain for interaction with the plasma membrane. Biochem J (1995) 1.23
Usefulness of suprasternal notch echocardiography for diagnosis of double aortic arch. Am J Cardiol (1986) 1.23
Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics (1993) 1.23
Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities. Circulation (1979) 1.23